성기 헤르페스 시장 규모는 향후 수년간 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 6.8%의 연평균 복합 성장률(CAGR)로 30억 5,000만 달러에 달할 것으로 예상됩니다. 예측 기간 중의 성장은 인지도 및 교육 향상, 치료 및 백신 발전, 이환율 증가, 디지털 건강 기술, 의료 접근성 확대, STI 인식 제고 프로그램 증가에 기인합니다. 예측 기간의 주요 동향으로는 원격의료의 채택, 항바이러스 치료의 발전, 백신 연구개발, 의료 접근성 확대, 인식 개선 캠페인 강화, AI와 데이터 분석의 통합 등이 있습니다.
성기 헤르페스 시장은성 건강에 대한 관심이 높아짐에 따라 성장세를 보이고 있습니다. 이러한 관심은 전반적인 웰빙과 삶의 질에 있으며,성 건강이 차지하는 중요한 역할에 대한 이해 증가를 반영합니다. 성기 헤르페스성 건강 서비스는 진단, 치료, 상담 및 지속적인 관리를 포함합니다. 이러한 서비스는 성병의 발생을 관리하고, 전염을 예방하며, 성병과 관련된 정서적, 관계적 문제를 해결하는 데 도움을 줍니다. 특히 지방정부협회는 2022년성 건강 상담 건수가 33% 급증하여 총 450만 건에 달하고, 진단 검사 건수도 2021년 대비 13% 증가하여 총 220만 건에 달할 것이라고 보고했습니다. 이처럼성 건강에 대한 관심이 높아지면서 성기 헤르페스 시장을 촉진할 것으로 예상됩니다.
성기 헤르페스 시장의 주요 기업은 기술력과 시장 입지를 강화하기 위해 전략적 파트너십을 맺고 있습니다. 이러한 파트너십은 공동의 목적을 위해 자원과 전문 지식을 모으기 위한 조직 간의 협력적 노력입니다. 예를 들어 2022년 6월 Eurocine Vaccines AB는 Redbiotec AG와 연구 협력 계약을 체결했습니다. 이 제휴를 통해 Eurocine Vaccines는 mRNA 및 단백질 기반 기술을 활용하여 단순 헤르페스 바이러스 2형(HSV-2)을 표적으로 하는 백신 후보물질의 개발, 제조 및 상업화에 대한 독점적인 세계 권리를 부여받게 되었습니다. 이후 제3자와의 라이선스 계약이 체결될 때까지 개발, 제조, 상업화에 관한 모든 활동을 관리하고 자금을 지원합니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스 및 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 성기 헤르페스 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 용도 산업의 분석
- 세계의 성기 헤르페스 시장 : 성장률 분석
- 세계의 성기 헤르페스 시장 실적 : 규모와 성장, 2019-2024
- 세계의 성기 헤르페스 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 성기 헤르페스 TAM(Total Addressable Market)
제6장 시장 세분화
- 세계의 성기 헤르페스 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 진단
- 치료
- 세계의 성기 헤르페스 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 경구
- 주사제
- 토픽
- 세계의 성기 헤르페스 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원 약국
- 소매 약국
- 기타 유통 채널
- 세계의 성기 헤르페스 시장, 진단의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 중합효소 연쇄 반응(PCR) 검사
- 바이러스 배양 검사
- 혈액 항체 검사(혈청학)
- 항원 탐지 검사
- POC(Point of Care) 신속 검사
- 세계의 성기 헤르페스 시장, 치료의 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 항바이러스제
- Acyclovir
- Valacyclovir
- Famciclovir
- Topical Treatments
- Acyclovir Cream
- Docosanol Cream
- 예방 요법
- 억제 요법
- 예방 백신(개발중)
- 통증 관리약
- 진통제
- 국소 마취제
제7장 지역별·국가별 분석
- 세계의 성기 헤르페스 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 성기 헤르페스 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 성기 헤르페스 시장 : 경쟁 구도
- 성기 헤르페스 시장 : 기업 개요
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
- Abbott Laboratories
- Novartis AG
- GlaxoSmithKline plc
- BioNTech SE
- Viatris Inc.
- Teva Pharmaceuticals Inc.
- Sandoz Inc.
- Fresenius Kabi AG
- Valeant Pharmaceuticals International Inc.
- Sun Pharmaceutical Industries Ltd.
- Bausch+Lomb Corporation
- Dr. Reddy's Laboratories Ltd.
- Apotex Inc.
- Zydus Group
- Genocea Biosciences Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 성기 헤르페스 시장 2029 : 새로운 기회를 제공하는 국가
- 성기 헤르페스 시장 2029 : 새로운 기회를 제공하는 부문
- 성기 헤르페스 시장 2029 : 성장 전략
제36장 부록
KSA
Genital herpes is a sexually transmitted infection (STI) caused primarily by the herpes simplex virus type 2 (HSV-2) or, less commonly, by the herpes simplex virus type 1 (HSV-1). It typically appears as sores or blisters on the genital area, buttocks, or anal region. Transmission occurs through sexual contact with an infected person. Antiviral medications are used to manage symptoms and reduce the risk of transmission to sexual partners.
The diagnosis and treatment of genital herpes involve identifying the infection in patients through methods such as physical examinations, laboratory tests, and reviewing patient history. Treatment methods include oral, injectable, and topical medications, distributed through hospital pharmacies, retail pharmacies, and other channels.
The genital herpes market research report is one of a series of new reports from the business research company that provides genital herpes market statistics, including genital herpes industry global market size, regional shares, competitors with an genital herpes market share, detailed genital herpes market segments, market trends and opportunities, and any further data you may need to thrive in the genital herpes industry. This genital herpes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The genital herpes market size has grown strongly in recent years. It will grow from $2.19 billion in 2024 to $2.34 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to increasing awareness and diagnosis, increasing advancements in treatment, improved access to healthcare, public health campaigns, and socio-demographic factors.
The genital herpes market size is expected to see strong growth in the next few years. It will grow to $3.05 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to growing awareness and education, advancements in treatment and vaccines, increasing incidence rates, digital health technologies, expanding healthcare access, and rising STI awareness programs. Major trends in the forecast period include the adoption of telemedicine, advancements in antiviral therapies, research and development in vaccines, expansion of healthcare access, enhanced public awareness campaigns, and the integration of AI and data analytics.
The genital herpes market is poised for growth, driven by increasing attention to sexual health. This focus reflects a growing understanding of its pivotal role in overall well-being and life quality. Sexual health services for genital herpes encompass diagnosis, treatment, counseling, and ongoing management. These services support individuals in managing outbreaks, preventing transmission, and addressing emotional and relationship challenges linked to the condition. Notably, the Local Government Association reported a 33% surge in sexual health consultations in 2022, totaling 4.5 million, along with a 13% increase in diagnostic tests, totaling 2.2 million compared to 2021. Thus, the heightened emphasis on sexual health is expected to boost the genital herpes market.
Major companies in the genital herpes market, are embracing strategic partnerships to bolster their technological capabilities and market presence. These partnerships involve collaborative efforts between organizations to combine resources and expertise toward shared objectives. For instance, in June 2022, Eurocine Vaccines AB entered into a research and collaboration agreement with Redbiotec AG. This partnership grants Eurocine Vaccines exclusive global rights for developing, manufacturing, and commercializing vaccine candidates targeting Herpes Simplex Virus Type 2 (HSV-2), utilizing mRNA- and protein-based technologies. Eurocine Vaccines will manage and finance all activities related to development, manufacturing, and commercialization until a subsequent out-licensing agreement with a third party is secured.
In July 2022, Flerie Invest AB, a Sweden-based investment company specializing in the pharmaceuticals and healthcare sectors, acquired a 15% stake in Eurocine Vaccines AB for an undisclosed sum. This investment is aimed at accelerating the development of medical innovations that address critical patient needs. Flerie Invest intends to support the advancement of Eurocine Vaccines' pipeline of products under development, consistent with its strategy of investing in the biotechnology and life sciences industries. Eurocine Vaccines AB, headquartered in Sweden, focuses on developing therapies and products for the treatment of genital herpes disease.
Major companies operating in the genital herpes market are Pfizer Inc, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi SA, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, BioNTech SE, Viatris Inc, Teva Pharmaceuticals Inc, Sandoz Inc, Fresenius Kabi AG, Valeant Pharmaceuticals International Inc, Sun Pharmaceutical Industries Ltd, Bausch + Lomb Corporation, Dr Reddy's Laboratories Ltd, Apotex Inc, Zydus Group, Genocea Biosciences Inc, Glenmark Pharmaceuticals Inc, Maruho Co Ltd, Romark Laboratories, Eurocine Vaccines AB, Vical Incorporated
North America was the largest region in the genital herpes market in 2024. The regions covered in the genital herpes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the genital herpes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The genital herpes market consists of revenues earned by entities by providing services such as diagnostic testing, patient education, counseling, and management of symptoms and outbreaks. The market value includes the value of related goods sold by the service provider or included within the service offering. The genital herpes market also includes sales of antiviral medications, topical treatments, diagnostic test kits, and preventive products such as vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Genital Herpes Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on genital herpes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for genital herpes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genital herpes market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Diagnosis; Treatment
- 2) By Route Of Administration: Oral; Injectable; Topical
- 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Other Distribution Channel
- Subsegments:
- 1) By Diagnosis: Polymerase Chain Reaction (PCR) Tests; Viral Culture Tests; Blood Antibody Tests (Serology); Antigen Detection Tests; Point-Of-Care Rapid Tests
- 2) By Treatment: Antiviral Medications; Acyclovir; Valacyclovir; Famciclovir; Topical Treatments; Acyclovir Cream; Docosanol Cream; Preventive Therapies; Suppressive Therapy; Prophylactic Vaccines (Under Development); Pain Management Medications; Analgesics; Topical Anesthetics
- Companies Mentioned: Pfizer Inc; Roche Holding AG; Merck & Co. Inc. ; AbbVie Inc.; Sanofi SA
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Genital Herpes Market Characteristics
3. Genital Herpes Market Trends And Strategies
4. Genital Herpes Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Genital Herpes Growth Analysis And Strategic Analysis Framework
- 5.1. Global Genital Herpes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Genital Herpes Market Growth Rate Analysis
- 5.4. Global Genital Herpes Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Genital Herpes Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Genital Herpes Total Addressable Market (TAM)
6. Genital Herpes Market Segmentation
- 6.1. Global Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Diagnosis
- Treatment
- 6.2. Global Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Injectable
- Topical
- 6.3. Global Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacy
- Retail Pharmacy
- Other Distribution Channel
- 6.4. Global Genital Herpes Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Polymerase Chain Reaction (PCR) Tests
- Viral Culture Tests
- Blood Antibody Tests (Serology)
- Antigen Detection Tests
- Point-Of-Care Rapid Tests
- 6.5. Global Genital Herpes Market, Sub-Segmentation Of Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antiviral Medications
- Acyclovir
- Valacyclovir
- Famciclovir
- Topical Treatments
- Acyclovir Cream
- Docosanol Cream
- Preventive Therapies
- Suppressive Therapy
- Prophylactic Vaccines (Under Development)
- Pain Management Medications
- Analgesics
- Topical Anesthetics
7. Genital Herpes Market Regional And Country Analysis
- 7.1. Global Genital Herpes Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Genital Herpes Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Genital Herpes Market
- 8.1. Asia-Pacific Genital Herpes Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Genital Herpes Market
- 9.1. China Genital Herpes Market Overview
- 9.2. China Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Genital Herpes Market
- 10.1. India Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Genital Herpes Market
- 11.1. Japan Genital Herpes Market Overview
- 11.2. Japan Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Genital Herpes Market
- 12.1. Australia Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Genital Herpes Market
- 13.1. Indonesia Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Genital Herpes Market
- 14.1. South Korea Genital Herpes Market Overview
- 14.2. South Korea Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Genital Herpes Market
- 15.1. Western Europe Genital Herpes Market Overview
- 15.2. Western Europe Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Genital Herpes Market
- 16.1. UK Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Genital Herpes Market
- 17.1. Germany Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Genital Herpes Market
- 18.1. France Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Genital Herpes Market
- 19.1. Italy Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Genital Herpes Market
- 20.1. Spain Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Genital Herpes Market
- 21.1. Eastern Europe Genital Herpes Market Overview
- 21.2. Eastern Europe Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Genital Herpes Market
- 22.1. Russia Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Genital Herpes Market
- 23.1. North America Genital Herpes Market Overview
- 23.2. North America Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Genital Herpes Market
- 24.1. USA Genital Herpes Market Overview
- 24.2. USA Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Genital Herpes Market
- 25.1. Canada Genital Herpes Market Overview
- 25.2. Canada Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Genital Herpes Market
- 26.1. South America Genital Herpes Market Overview
- 26.2. South America Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Genital Herpes Market
- 27.1. Brazil Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Genital Herpes Market
- 28.1. Middle East Genital Herpes Market Overview
- 28.2. Middle East Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Genital Herpes Market
- 29.1. Africa Genital Herpes Market Overview
- 29.2. Africa Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Genital Herpes Market Competitive Landscape And Company Profiles
- 30.1. Genital Herpes Market Competitive Landscape
- 30.2. Genital Herpes Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
31. Genital Herpes Market Other Major And Innovative Companies
- 31.1. Abbott Laboratories
- 31.2. Novartis AG
- 31.3. GlaxoSmithKline plc
- 31.4. BioNTech SE
- 31.5. Viatris Inc.
- 31.6. Teva Pharmaceuticals Inc.
- 31.7. Sandoz Inc.
- 31.8. Fresenius Kabi AG
- 31.9. Valeant Pharmaceuticals International Inc.
- 31.10. Sun Pharmaceutical Industries Ltd.
- 31.11. Bausch + Lomb Corporation
- 31.12. Dr. Reddy's Laboratories Ltd.
- 31.13. Apotex Inc.
- 31.14. Zydus Group
- 31.15. Genocea Biosciences Inc.
32. Global Genital Herpes Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Genital Herpes Market
34. Recent Developments In The Genital Herpes Market
35. Genital Herpes Market High Potential Countries, Segments and Strategies
- 35.1 Genital Herpes Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Genital Herpes Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Genital Herpes Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
